Engineered heart muscle passes early clinical milestone

by AiNewsBlog Jun, 16

written by AiNewsBlog Jun, 16 0 comments

Engineered heart muscle passes early clinical milestone

RESEARCH HIGHLIGHT
16 June 2026

Engineered heart muscle allografts derived from induced pluripotent stem cells show promising early outcomes in patients with treatment-refractory advanced heart failure with reduced left ventricular ejection fraction, in support of further clinical investigation.

AiNewsBlog

Leave a Comment Cancel Reply

Name	Price	7d %	Volume
Bitcoin btc	$65,729	6.43%	$27,321,287,440
Ethereum eth	$1,793	8.55%	$15,656,721,068
XRP xrp	$1.22	7.27%	$2,048,504,371
Solana sol	$74	13.64%	$2,527,726,866
Dogecoin doge	$0.088	3.28%	$783,289,292

At Srivax, we believe in delivering fast, accurate, and relevant news to empower, inform, and engage our readers across the globe. We are an independent digital news platform built for the modern world — where information moves fast, and truth matters.